U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BRII-198
Preferred Name English
ROMLUSEVIMAB
INN   USAN  
Official Name English
ROMLUSEVIMAB [USAN]
Common Name English
Romlusevimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) (SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HOMO SAPIENS (1-448) (VH (HOMO SAPIENS IGHV7-4-1*02 (96%)-(IGHD)-IGHJ
Common Name English
romlusevimab [INN]
Common Name English
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN,RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONALANTIBODY
Common Name English
BRII198
Code English
Code System Code Type Description
FDA UNII
SM01RRU9KK
Created by admin on Wed Apr 02 09:14:33 GMT 2025 , Edited by admin on Wed Apr 02 09:14:33 GMT 2025
PRIMARY
USAN
JK-256
Created by admin on Wed Apr 02 09:14:33 GMT 2025 , Edited by admin on Wed Apr 02 09:14:33 GMT 2025
PRIMARY
INN
11992
Created by admin on Wed Apr 02 09:14:33 GMT 2025 , Edited by admin on Wed Apr 02 09:14:33 GMT 2025
PRIMARY
SMS_ID
300000026355
Created by admin on Wed Apr 02 09:14:33 GMT 2025 , Edited by admin on Wed Apr 02 09:14:33 GMT 2025
PRIMARY
CAS
2509447-08-7
Created by admin on Wed Apr 02 09:14:33 GMT 2025 , Edited by admin on Wed Apr 02 09:14:33 GMT 2025
PRIMARY
NCI_THESAURUS
C175226
Created by admin on Wed Apr 02 09:14:33 GMT 2025 , Edited by admin on Wed Apr 02 09:14:33 GMT 2025
PRIMARY
ACTIVE MOIETY
AMUBARVIMAB
SUBSTANCE RECORD
ROMLUSEVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966